The pharmaceutical industry is rapidly evolving, with substantial demand for high-performance Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, represents example of this trend. To meet https://socialmediastore.net/story21488041/leading-us-based-dulaglutide-api-manufacturing-services